China Shineway Pharmaceutical Group Limited

Research China Shineway Pharmaceutical Group Limited (C1S) on Bullrun: market cap EUR 619.43M, P/E 5.1, dividend yield 8.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerC1S
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 619.43M
• P/E5.1
• Dividend yield8.1%
• Financial periodFY2025
• RevenueEUR 3.14B
• Revenue growth-17.0%
• Net incomeEUR 949.95M
• Free cash flowEUR 974.13M
• Gross margin72.3%

Valuation Snapshot

latest market cap is EUR 619.43M; P/E is 5.1; dividend yield is 8.1%.

About China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets;

Frequently asked questions

What is China Shineway Pharmaceutical Group Limited's market cap?

China Shineway Pharmaceutical Group Limited's market capitalization is EUR 619.43M.

What is China Shineway Pharmaceutical Group Limited's P/E ratio?

China Shineway Pharmaceutical Group Limited's price-to-earnings (P/E) ratio is 5.1.

Does China Shineway Pharmaceutical Group Limited pay a dividend?

China Shineway Pharmaceutical Group Limited has a dividend yield of 8.1%.

What does China Shineway Pharmaceutical Group Limited do?

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong.